uniQure N.V. (QURE)
USD 8.34
(-4.79%)
USD 8.34
(-4.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -308.47 Million USD | -143.3% |
| 2022 | -126.78 Million USD | -138.47% |
| 2021 | 329.58 Million USD | 363.62% |
| 2020 | -125.02 Million USD | 2.33% |
| 2019 | -128.01 Million USD | -53.67% |
| 2018 | -83.3 Million USD | -3.63% |
| 2017 | -80.38 Million USD | -9.56% |
| 2016 | -73.37 Million USD | 6.11% |
| 2015 | -78.14 Million USD | -73.51% |
| 2014 | -45.04 Million USD | -21.62% |
| 2013 | -37.03 Million USD | -90.29% |
| 2012 | -19.46 Million USD | 13.2% |
| 2011 | -22.42 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -65.61 Million USD | 10.37% |
| 2024 Q2 | -56.29 Million USD | 14.2% |
| 2024 Q3 | -44.37 Million USD | 21.17% |
| 2023 Q3 | -89.57 Million USD | -30.81% |
| 2023 FY | -308.47 Million USD | -143.3% |
| 2023 Q1 | -77.22 Million USD | -1234.52% |
| 2023 Q4 | -73.2 Million USD | 18.27% |
| 2023 Q2 | -68.47 Million USD | 11.33% |
| 2022 Q2 | -39.06 Million USD | 16.32% |
| 2022 Q4 | 6.8 Million USD | 114.22% |
| 2022 FY | -126.78 Million USD | -138.47% |
| 2022 Q1 | -46.67 Million USD | -668.69% |
| 2022 Q3 | -47.85 Million USD | -22.52% |
| 2021 Q2 | 399.46 Million USD | 1061.28% |
| 2021 Q1 | -41.55 Million USD | -5845.06% |
| 2021 FY | 329.58 Million USD | 363.62% |
| 2021 Q4 | 8.2 Million USD | 122.47% |
| 2021 Q3 | -36.53 Million USD | -109.14% |
| 2020 Q2 | -42.55 Million USD | -51.97% |
| 2020 FY | -125.02 Million USD | 2.33% |
| 2020 Q1 | -27.99 Million USD | 32.41% |
| 2020 Q4 | -699 Thousand USD | 98.7% |
| 2020 Q3 | -53.77 Million USD | -26.38% |
| 2019 Q2 | -31.39 Million USD | -13.06% |
| 2019 FY | -128.01 Million USD | -53.67% |
| 2019 Q4 | -41.42 Million USD | -75.5% |
| 2019 Q3 | -23.6 Million USD | 24.83% |
| 2019 Q1 | -27.77 Million USD | -26.88% |
| 2018 Q3 | -22.03 Million USD | -7.01% |
| 2018 FY | -83.3 Million USD | -3.63% |
| 2018 Q1 | -18.78 Million USD | 31.61% |
| 2018 Q2 | -20.59 Million USD | -9.6% |
| 2018 Q4 | -21.88 Million USD | 0.67% |
| 2017 FY | -80.38 Million USD | -9.56% |
| 2017 Q2 | -21.26 Million USD | -4.92% |
| 2017 Q3 | -10.24 Million USD | 51.83% |
| 2017 Q4 | -27.47 Million USD | -168.17% |
| 2017 Q1 | -20.27 Million USD | -50.9% |
| 2016 Q1 | -23.31 Million USD | -71.5% |
| 2016 FY | -73.37 Million USD | 6.11% |
| 2016 Q3 | -15.16 Million USD | 29.46% |
| 2016 Q2 | -21.5 Million USD | 7.79% |
| 2016 Q4 | -13.43 Million USD | 11.44% |
| 2015 Q1 | -13.68 Million USD | -12.15% |
| 2015 Q4 | -13.59 Million USD | 53.24% |
| 2015 Q3 | -29.07 Million USD | -37.27% |
| 2015 FY | -78.14 Million USD | -73.51% |
| 2015 Q2 | -21.18 Million USD | -54.78% |
| 2014 Q2 | -12.26 Million USD | -13.91% |
| 2014 Q4 | -12.2 Million USD | -6.16% |
| 2014 FY | -45.04 Million USD | -21.62% |
| 2014 Q1 | -10.76 Million USD | -13.71% |
| 2014 Q3 | -11.49 Million USD | 6.28% |
| 2013 Q1 | -6.63 Million USD | -9.13% |
| 2013 Q3 | -9.49 Million USD | 6.22% |
| 2013 Q4 | -9.46 Million USD | 0.29% |
| 2013 FY | -37.03 Million USD | -90.29% |
| 2013 Q2 | -10.12 Million USD | -52.69% |
| 2012 Q3 | -4.6 Million USD | 0.0% |
| 2012 Q4 | -6.07 Million USD | -31.85% |
| 2012 FY | -19.46 Million USD | 13.2% |
| 2011 FY | -22.42 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -494.084% |
| Jaguar Health, Inc. | -41.3 Million USD | -646.92% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -101.63% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -466.826% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 29.93% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 691.475% |
| ContextLogic Inc. | -317 Million USD | 2.688% |
| MiMedx Group, Inc. | 67.43 Million USD | 557.418% |
| MEI Pharma, Inc. | 17.77 Million USD | 1835.167% |
| AlloVir, Inc. | -190.41 Million USD | -62.0% |
| Novavax, Inc. | -545.06 Million USD | 43.405% |
| Aptorum Group Limited | -2.82 Million USD | -10820.94% |
| Ardelyx, Inc. | -66.06 Million USD | -366.917% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -50.275% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -502.978% |
| Vaxcyte, Inc. | -402.26 Million USD | 23.315% |
| Precigen, Inc. | -95.9 Million USD | -221.653% |
| Pharming Group N.V. | -10.54 Million USD | -2824.516% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -53.021% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1156.888% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1129.437% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -45.358% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1563.304% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1167.407% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1167.407% |
| Bicycle Therapeutics plc | -180.66 Million USD | -70.747% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -19.643% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1032.528% |
| Acelyrin, Inc. | -381.64 Million USD | 19.171% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -726.133% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -804.601% |
| Senti Biosciences, Inc. | -92.91 Million USD | -231.986% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -194.633% |
| AbCellera Biologics Inc. | -146.39 Million USD | -110.712% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -777.854% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -72.283% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -4514.48% |
| Chimerix, Inc. | -82.09 Million USD | -275.757% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -950.603% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1420.27% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -591.603% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -504.172% |
| Elevation Oncology, Inc. | -45.7 Million USD | -574.947% |
| Alkermes plc | 355.75 Million USD | 186.71% |
| Fortress Biotech, Inc. | -60.63 Million USD | -408.729% |
| Fortress Biotech, Inc. | -60.63 Million USD | -408.729% |
| Agenus Inc. | -245.76 Million USD | -25.52% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -278.129% |
| Dyadic International, Inc. | -6.79 Million USD | -4439.471% |
| ImmuCell Corporation | -5.77 Million USD | -5241.982% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -32857.051% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -173.084% |
| Lantern Pharma Inc. | -15.96 Million USD | -1832.634% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1899.722% |
| Incyte Corporation | 597.59 Million USD | 151.62% |
| IO Biotech, Inc. | -86.08 Million USD | -258.349% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -429.185% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1521.104% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -422.998% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -87.44% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3528.726% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -320.573% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 17.438% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 46.15% |
| NextCure, Inc. | -62.72 Million USD | -391.81% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2989.105% |
| Onconetix, Inc. | -37.4 Million USD | -724.594% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -681.372% |
| Opthea Limited | -220.24 Million USD | -40.063% |
| PDS Biotechnology Corporation | -42.94 Million USD | -618.356% |
| PureTech Health plc | -65.69 Million USD | -369.547% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -318.049% |
| Seer, Inc. | -86.27 Million USD | -257.544% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2459324.573% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -849.601% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2259.862% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -984.205% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -436.362% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -395.507% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -132.826% |
| ChromaDex Corporation | -4.93 Million USD | -6147.023% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -8497.492% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -202.222% |
| CRISPR Therapeutics AG | -153.61 Million USD | -100.819% |
| Precision BioSciences, Inc. | -61.31 Million USD | -403.071% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -91.687% |
| Innoviva, Inc. | 179.72 Million USD | 271.642% |
| Summit Therapeutics Inc. | -614.92 Million USD | 49.835% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -360.449% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -369.061% |
| ESSA Pharma Inc. | -26.58 Million USD | -1060.462% |
| GlycoMimetics, Inc. | -36.89 Million USD | -735.997% |
| GT Biopharma, Inc. | -7.59 Million USD | -3960.524% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -27.808% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 531.982% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -528.009% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3000.984% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -25.604% |
| Aptose Biosciences Inc. | -51.2 Million USD | -502.414% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -213.819% |
| Soligenix, Inc. | -6.14 Million USD | -4923.474% |
| Century Therapeutics, Inc. | -136.67 Million USD | -125.705% |
| Kura Oncology, Inc. | -152.63 Million USD | -102.107% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -245.758% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2827.292% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 54652.496% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -54114.06% |
| Autolus Therapeutics plc | -208.38 Million USD | -48.034% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -329.049% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -335.734% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1323.657% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -36.949% |
| GRI Bio, Inc. | -13.03 Million USD | -2266.173% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -7360.931% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -148.604% |
| IGM Biosciences, Inc. | -246.41 Million USD | -25.186% |
| INmune Bio, Inc. | -30 Million USD | -927.986% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -179.017% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -631.098% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1832.619% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1853.013% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -416.843% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -204.92% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -11.716% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -29.671% |
| Verastem, Inc. | -87.36 Million USD | -253.083% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -469.274% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -91.202% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -164.429% |
| Histogen Inc. | -10.62 Million USD | -2804.416% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2059.189% |
| Surrozen, Inc. | -43.04 Million USD | -616.691% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2002.638% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5964.011% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -489.385% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1121.066% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1045.141% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3591.215% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -104.175% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -530.499% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -937.773% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2861.094% |
| Apollomics, Inc. | -172.6 Million USD | -78.723% |
| Amarin Corporation plc | -59.11 Million USD | -421.853% |
| Mesoblast Limited | -87.95 Million USD | -250.719% |
| Turnstone Biologics Corp. | -55.2 Million USD | -458.837% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -109.903% |
| Synaptogenix, Inc. | -6.03 Million USD | -5008.517% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1803.245% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -295.383% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6338.071% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3571.397% |
| Exelixis, Inc. | 207.76 Million USD | 248.474% |
| Better Therapeutics, Inc. | -39.76 Million USD | -675.85% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -114.298% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 41.646% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2434.319% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -3857.54% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -903.213% |
| Gritstone bio, Inc. | -138.49 Million USD | -122.744% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -378.52% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7612.046% |
| Avid Bioservices, Inc. | -140.75 Million USD | -119.163% |
| Insmed Incorporated | -749.56 Million USD | 58.846% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1930.862% |
| MediWound Ltd. | -6.71 Million USD | -4493.18% |
| OmniAb, Inc. | -50.61 Million USD | -509.411% |
| Alector, Inc. | -130.39 Million USD | -136.579% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -171.251% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -494.978% |
| Zai Lab Limited | -334.62 Million USD | 7.812% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 4.787% |
| Aura Biosciences, Inc. | -76.4 Million USD | -303.725% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -31.473% |
| Immunic, Inc. | -93.61 Million USD | -229.528% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -127.001% |
| Veracyte, Inc. | -74.4 Million USD | -314.599% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3918.969% |
| FibroGen, Inc. | -284.23 Million USD | -8.53% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1075.961% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4305.639% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1537.992% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 174.362% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1267.67% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 726.084% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2534.328% |
| Galecto, Inc. | -38.34 Million USD | -704.396% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1535.1% |
| Fortrea Holdings Inc. | -3.4 Million USD | -8972.882% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -143.579% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1671.742% |
| XBiotech Inc. | -24.55 Million USD | -1156.171% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -378.52% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -392.147% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -213.411% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1339.67% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -458.908% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 49.15% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -351.949% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -541716.841% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -36.17% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1285.327% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -40.402% |
| NexImmune, Inc. | -32.34 Million USD | -853.729% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -5735.121% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2096.215% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 107.802% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1173.597% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2557.042% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -164.112% |
| Ainos, Inc. | -13.77 Million USD | -2140.129% |
| Pluri Inc. | -20.88 Million USD | -1376.819% |
| Prothena Corporation plc | -147.02 Million USD | -109.809% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -170.901% |
| Celularity Inc. | -196.29 Million USD | -57.15% |
| Rallybio Corporation | -74.56 Million USD | -313.709% |
| Cue Biopharma, Inc. | -50.73 Million USD | -508.042% |
| MeiraGTx Holdings plc | -84.02 Million USD | -267.118% |
| Omeros Corporation | -117.81 Million USD | -161.837% |
| Humacyte, Inc. | -110.77 Million USD | -178.47% |
| Immunocore Holdings plc | -55.28 Million USD | -457.958% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1615.291% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1245.244% |
| Blueprint Medicines Corporation | -506.98 Million USD | 39.154% |
| CalciMedica, Inc. | -34.35 Million USD | -797.861% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -355.823% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -118.152% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -86.067% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -8.905% |
| Pulmatrix, Inc. | -14.12 Million USD | -2084.534% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -776.482% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -273.288% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 35.893% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -194.15% |
| Cytokinetics, Incorporated | -526.24 Million USD | 41.381% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -755.339% |
| Nutriband Inc. | -5.48 Million USD | -5523.707% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -663.182% |
| Vor Biopharma Inc. | -117.86 Million USD | -161.726% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 107.093% |
| Evogene Ltd. | -23.87 Million USD | -1191.838% |
| ProKidney Corp. | -35.46 Million USD | -769.736% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -157.574% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -3831.965% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 52.04% |
| CorMedix Inc. | -46.33 Million USD | -565.695% |
| BioLineRx Ltd. | -60.61 Million USD | -408.922% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -203.19% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -651.176% |
| Atai Life Sciences N.V. | -40.22 Million USD | -666.9% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -282.489% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -308.467% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -5.574% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1006.608% |
| MediciNova, Inc. | -8.57 Million USD | -3498.873% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -150.232% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3582.513% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1087.973% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -28.942% |
| Biomea Fusion, Inc. | -117.25 Million USD | -163.083% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 50.77% |
| Mereo BioPharma Group plc | -29.46 Million USD | -946.895% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -101.406% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -47.343% |
| Absci Corporation | -110.56 Million USD | -178.999% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -923.144% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -205.917% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -30.746% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2290.273% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -59.865% |
| Allakos Inc. | -185.7 Million USD | -66.115% |
| Imunon, Inc. | -19.51 Million USD | -1480.724% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -216.924% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 390.633% |
| BioAtla, Inc. | -123.46 Million USD | -149.857% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2434.319% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1818.634% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 5.741% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -734.875% |
| XOMA Corporation | -40.83 Million USD | -655.499% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -202.815% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -160.29% |
| aTyr Pharma, Inc. | -50.38 Million USD | -512.193% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -251.827% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -103.268% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -29.758% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -778.379% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3712.164% |
| Akari Therapeutics, Plc | -10 Million USD | -2982.314% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -458092.351% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 209.547% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4528.397% |
| UroGen Pharma Ltd. | -102.24 Million USD | -201.708% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -188.856% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -3866.449% |
| Orgenesis Inc. | -55.36 Million USD | -457.212% |
| Entera Bio Ltd. | -8.88 Million USD | -3370.334% |
| GH Research PLC | -35.58 Million USD | -766.828% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1380.221% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -298.612% |
| Xencor, Inc. | -126.08 Million USD | -144.655% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -8091.779% |
| Replimune Group, Inc. | -215.79 Million USD | -42.95% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1350.532% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 12394.859% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4528.397% |
| Portage Biotech Inc. | -75.33 Million USD | -309.453% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3582.513% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -219.154% |
| OncoCyte Corporation | -27.78 Million USD | -1010.392% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2199.121% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2673.704% |
| Purple Biotech Ltd. | -19.88 Million USD | -1451.7% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -4294.9% |
| scPharmaceuticals Inc. | -54.81 Million USD | -462.813% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1662.113% |
| HilleVax, Inc. | -123.56 Million USD | -149.646% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2952.122% |
| Tharimmune, Inc. | -9.31 Million USD | -3210.172% |
| Genprex, Inc. | -30.86 Million USD | -899.59% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -30.753% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -925.048% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -17210.774% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -5724.719% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1833300.097% |
| Savara Inc. | -54.69 Million USD | -463.966% |
| Curis, Inc. | -47.41 Million USD | -550.619% |
| Daré Bioscience, Inc. | -30.16 Million USD | -922.758% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1897.256% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -5439.199% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -934.64% |
| BeiGene, Ltd. | -881.7 Million USD | 65.014% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1348.662% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 29.308% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -290.701% |
| Erasca, Inc. | -125.04 Million USD | -146.7% |
| bluebird bio, Inc. | -211.91 Million USD | -45.568% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6068.947% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 284.007% |
| DBV Technologies S.A. | -72.72 Million USD | -324.165% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6068.947% |
| Moderna, Inc. | -4.71 Billion USD | 93.456% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -668.18% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -5317.597% |
| Molecular Templates, Inc. | -8.12 Million USD | -3697.12% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -410.827% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -176.913% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -127.908% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -543.749% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -118.115% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -60.323% |
| MacroGenics, Inc. | -9.05 Million USD | -3305.586% |
| RenovoRx, Inc. | -10.23 Million USD | -2914.836% |
| Adicet Bio, Inc. | -142.65 Million USD | -116.236% |
| Prime Medicine, Inc. | -198.13 Million USD | -55.692% |
| Aditxt, Inc. | -32.38 Million USD | -852.656% |
| Adagene Inc. | -18.94 Million USD | -1528.164% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4118.951% |
| Quantum-Si incorporated | -95.96 Million USD | -221.465% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -159.162% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2016.085% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 333.113% |
| SciSparc Ltd. | -5.12 Million USD | -5922.608% |
| Vericel Corporation | -3.18 Million USD | -9594.469% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -256422.028% |
| Minerva Neurosciences, Inc. | -30 Million USD | -928.077% |
| Generation Bio Co. | -126.61 Million USD | -143.64% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -323.205% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -274.176% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -17.677% |
| Invivyd, Inc. | -198.64 Million USD | -55.293% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 9.795% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3451.205% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1452.618% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3024.144% |
| 2seventy bio, Inc. | -217.57 Million USD | -41.783% |
| ADMA Biologics, Inc. | -28.23 Million USD | -992.383% |
| Clene Inc. | -49.5 Million USD | -523.138% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1284.083% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -524.02% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1087.973% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 5.971% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -847.911% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1457.738% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -212.251% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -312.658% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -91.834% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 49.846% |
| Evaxion Biotech A/S | -22.12 Million USD | -1294.251% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -282.082% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -54.187% |
| Trevena, Inc. | -40.28 Million USD | -665.663% |
| Surrozen, Inc. | -43.04 Million USD | -616.691% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -346.203% |
| Cingulate Inc. | -23.53 Million USD | -1210.723% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -4362.934% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -673.904% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3900.662% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -241.955% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -403.342% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -418.424% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2480.32% |
| Kronos Bio, Inc. | -112.67 Million USD | -173.782% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -345.797% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -12162755.892% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -259.134% |
| Statera Biopharma, Inc. | -174.4 Million USD | -76.871% |
| ImmunityBio, Inc. | -583.19 Million USD | 47.106% |
| Korro Bio, Inc. | -81.17 Million USD | -280.03% |
| Kineta, Inc. | -14.09 Million USD | -2087.942% |
| BioVie Inc. | -32.12 Million USD | -860.376% |
| Codexis, Inc. | -76.24 Million USD | -304.614% |
| Celularity Inc. | -196.29 Million USD | -57.15% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -43.793% |
| Celcuity Inc. | -63.77 Million USD | -383.666% |
| Virax Biolabs Group Limited | -6.73 Million USD | -4481.218% |
| Cibus, Inc. | -267.62 Million USD | -15.264% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -664.961% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -761.406% |
| IN8bio, Inc. | -30 Million USD | -928.02% |
| Kodiak Sciences Inc. | -260.49 Million USD | -18.422% |
| Annexon, Inc. | -134.23 Million USD | -129.801% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -163.285% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -403.819% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -877.929% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 15.782% |
| Eyenovia, Inc. | -27.26 Million USD | -1031.569% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1528.734% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -57559.439% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -303.746% |
| Arcellx, Inc. | -70.69 Million USD | -336.381% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -644.379% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -130.524% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -926.993% |
| Moolec Science SA | -51.78 Million USD | -495.645% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -489.024% |
| Geron Corporation | -184.12 Million USD | -67.535% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -634.926% |
| Royalty Pharma plc | 1.13 Billion USD | 127.183% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -126.895% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3369.24% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1352.124% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -79.692% |
| Humacyte, Inc. | -110.77 Million USD | -178.47% |
| Structure Therapeutics Inc. | -89.62 Million USD | -244.207% |
| 89bio, Inc. | -142.18 Million USD | -116.949% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -347.329% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2872.709% |
| Genelux Corporation | -28.29 Million USD | -990.144% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -961.338% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -74.164% |
| Notable Labs, Ltd. | -11.26 Million USD | -2638.619% |
| Liquidia Corporation | -78.5 Million USD | -292.956% |
| Mustang Bio, Inc. | -51.6 Million USD | -497.802% |
| Immunovant, Inc. | -259.33 Million USD | -18.949% |
| Quantum-Si incorporated | -95.96 Million USD | -221.465% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -323.449% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1491.652% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -221.365% |
| Acasti Pharma Inc. | -12.85 Million USD | -2300.047% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1273.586% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1832.619% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -69.128% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -7071.377% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2373.761% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -946.007% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -691.213% |
| PepGen Inc. | -78.62 Million USD | -292.336% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -936.239% |
| United Therapeutics Corporation | 984.8 Million USD | 131.324% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1285.795% |
| Solid Biosciences Inc. | -96.01 Million USD | -221.281% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6338.071% |
| Immuneering Corporation | -53.47 Million USD | -476.9% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -5964.011% |
| Silo Pharma, Inc. | -3.7 Million USD | -8235.705% |
| Belite Bio, Inc | -31.63 Million USD | -875.209% |
| XOMA Corporation | -40.83 Million USD | -655.499% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -467.42% |
| Bionomics Limited | -15.49 Billion USD | 98.009% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -267.301% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -957.99% |
| Cassava Sciences, Inc. | -97.21 Million USD | -217.309% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4118.951% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -149.921% |
| Forte Biosciences, Inc. | -31.47 Million USD | -880.042% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3661.146% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -961.229% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -57559.439% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1075.961% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1771.265% |
| Altimmune, Inc. | -88.44 Million USD | -248.772% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -103.503% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -957.99% |
| Compugen Ltd. | -18.75 Million USD | -1544.865% |
| Peak Bio, Inc. | -1259.26 USD | -24496667.943% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -569.891% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1318.224% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 8.947% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -271.866% |
| Zura Bio Limited | -60.36 Million USD | -411.064% |
| PolyPid Ltd. | -23.86 Million USD | -1192.596% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1860.831% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -271.866% |
| Instil Bio, Inc. | -156.08 Million USD | -97.632% |
| argenx SE | -295.05 Million USD | -4.55% |
| Immunome, Inc. | -106.8 Million USD | -188.821% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -625.933% |
| Verona Pharma plc | -54.36 Million USD | -467.378% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -208.734% |
| Shattuck Labs, Inc. | -87.29 Million USD | -253.362% |
| CervoMed Inc. | -2.17 Million USD | -14103.317% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -147.473% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2216.597% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -608.249% |
| Moolec Science SA | -51.78 Million USD | -495.645% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1783862.623% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -128.304% |
| AnaptysBio, Inc. | -163.61 Million USD | -88.534% |
| Design Therapeutics, Inc. | -66.86 Million USD | -361.365% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -278.9% |
| NeurAxis, Inc. | -14.62 Million USD | -2009.009% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -714.313% |
| Lumos Pharma, Inc. | -34.03 Million USD | -806.382% |
| Achilles Therapeutics plc | -69.66 Million USD | -342.802% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -208.734% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1447.41% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 10352.56% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -12162755.892% |
| Nutriband Inc. | -5.48 Million USD | -5523.707% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -206.343% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -534.637% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -300.148% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -808.089% |
| MoonLake Immunotherapeutics | -36 Million USD | -756.711% |
| Palisade Bio, Inc. | -12.3 Million USD | -2407.951% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -632.309% |
| Beam Therapeutics Inc. | -132.52 Million USD | -132.766% |
| Neurogene Inc. | -36.31 Million USD | -749.404% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -88.77% |
| AEON Biopharma, Inc. | -52.55 Million USD | -486.951% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -214.302% |
| Sesen Bio, Inc. | -19.88 Million USD | -1451.388% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -330.931% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2365.084% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 30.529% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -176.498% |
| Athira Pharma, Inc. | -117.67 Million USD | -162.151% |
| Vaccinex, Inc. | -20.25 Million USD | -1423.273% |
| HCW Biologics Inc. | -24.99 Million USD | -1134.195% |
| XOMA Corporation | -40.83 Million USD | -655.499% |
| Nektar Therapeutics | -276.05 Million USD | -11.745% |
| Arvinas, Inc. | -367.3 Million USD | 16.015% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -458092.351% |
| Merus N.V. | -154.93 Million USD | -99.096% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -216.622% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -882.884% |
| Rezolute, Inc. | -68.45 Million USD | -350.603% |
| Clene Inc. | -49.5 Million USD | -523.138% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1900.056% |
| BeyondSpring Inc. | -21.02 Million USD | -1367.126% |
| Synlogic, Inc. | -57.28 Million USD | -438.525% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2492.034% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2749.418% |
| Peak Bio, Inc. | -1259.26 USD | -24496667.943% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -725.514% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2921.789% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -115.57% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 5.114% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -6578.509% |
| MannKind Corporation | -11.93 Million USD | -2484.001% |
| Ikena Oncology, Inc. | -68.16 Million USD | -352.539% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1367.894% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -231.936% |
| Gossamer Bio, Inc. | -179.81 Million USD | -71.551% |
| CohBar, Inc. | -11.96 Million USD | -2478.791% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1096.208% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -923.144% |
| Legend Biotech Corporation | -518.25 Million USD | 40.477% |
| Mural Oncology plc | -207.44 Million USD | -48.702% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -148.542% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1586.619% |
| Disc Medicine, Inc. | -76.42 Million USD | -303.614% |
| Champions Oncology, Inc. | -7.27 Million USD | -4139.665% |
| REGENXBIO Inc. | -263.49 Million USD | -17.072% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2806.585% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -549.359% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -712.137% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -207.976% |
| Vaxart, Inc. | -82.46 Million USD | -274.071% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 92524.265% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -721.677% |
| Cellectis S.A. | -101.05 Million USD | -205.245% |
| Longeveron Inc. | -21.41 Million USD | -1340.611% |
| Repare Therapeutics Inc. | -93.79 Million USD | -228.882% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 42.446% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -333.444% |
| Revolution Medicines, Inc. | -436.36 Million USD | 29.308% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -4594.537% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -900.772% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -344.922% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -376.546% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -3044.205% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 108.522% |
| Denali Therapeutics Inc. | -145.22 Million USD | -112.415% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -256422.028% |
| Veru Inc. | -93.15 Million USD | -231.153% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1041.285% |
| Cingulate Inc. | -23.53 Million USD | -1210.723% |
| Passage Bio, Inc. | -102.06 Million USD | -202.246% |
| Context Therapeutics Inc. | -23.96 Million USD | -1187.245% |
| Exicure, Inc. | -16.91 Million USD | -1723.803% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -63.288% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -716.857% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4640.474% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -67.036% |
| Nuvalent, Inc. | -126.21 Million USD | -144.399% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2833.512% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -255.066% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -909.946% |
| OmniAb, Inc. | -50.61 Million USD | -509.411% |
| Anew Medical, Inc. | 1.34 Million USD | 23016.0% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1822.58% |
| Lipocine Inc. | -16.35 Million USD | -1786.475% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -364.617% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -384.457% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -631.098% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -543.105% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1455.534% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 43.032% |
| Ocugen, Inc. | -63.07 Million USD | -389.042% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -222.231% |
| Q32 Bio Inc. | -112.96 Million USD | -173.084% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1694.311% |
| Alumis Inc. Common Stock | -154.99 Million USD | -99.027% |
| Equillium, Inc. | -13.33 Million USD | -2213.296% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -411.013% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3761.847% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1536.382% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -422.118% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -169.35% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1578.522% |
| Dominari Holdings Inc. | -22.88 Million USD | -1248.125% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3583.577% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1423.348% |
| Bio-Techne Corporation | 168.1 Million USD | 283.503% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 12.386% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 339.403% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -153.199% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -713.089% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -173.857% |
| Nkarta, Inc. | -117.5 Million USD | -162.532% |
| BioCardia, Inc. | -11.57 Million USD | -2565.958% |
| Iterum Therapeutics plc | -38.37 Million USD | -703.935% |